Table 2.
Correlations between HBcrAg and HBV DNA, HBsAg, anti-HBc, HAI score, and Ishak fibrosis score at baseline and 78 weeks after ETV therapy.
| HBcrAg | ||||||||
| HBeAg-positive | HBeAg-negative | |||||||
| Baseline | 78-week | Baseline | 78-week | |||||
| Variables | r | P | r | P | r | P | r | P |
| HBV DNA | 0.641 | <0.001 | −0.001 | 0.992 | 0.616 | <0.001 | −0.071 | 0.630 |
| HBsAg | 0.495 | <0.001 | 0.164 | 0.116 | 0.221 | 0.115 | 0.208 | 0.151 |
| Anti-HBc | −0.102 | 0.343 | −0.263 | 0.014 | 0.050 | 0.614 | −0.291 | 0.045 |
| HAI | 0.232 | 0.025 | 0.035 | 0.739 | 0.118 | 0.405 | −0.157 | 0.283 |
| F | −0.292 | 0.005 | 0.039 | 0.709 | 0.115 | 0.417 | 0.180 | 0.216 |
Anti-HBc: Anti-hepatitis B virus core antibody; F: Ishak fibrosis score; HAI: Histological activity index; HBcrAg: Hepatitis B core-related antigen; HBeAg: Hepatitis B e antigen; HBsAg: Hepatitis B surface antigen; HBV: Hepatitis B virus.